AI Small Cap Stocks Portfolio Up 3% W/e May 10th; Still Down 26% YTD

AI Small Cap Stocks Portfolio declined 23% in April but was up 2.5% w/e May 3rd and another 3.0% w/e May 10th.

Photo by Steve Johnson on Unsplash


Introduction

The munKNEE  AI Small Cap Stocks Portfolio declined 23% in April (see here) but was UP 2.5% w/e May3rd and another 3.0% w/e May 10th. This article highlights the performances of the Portfolio's 10 constituents, in descending order, last week and YTD along with their latest news, commentary, and/or analysis where available:


The munKNEE Small Cap AI Stocks Portfolio

  1. Innodata (INOD): UP 60.4% last week; UP 32.4% YTD
  2. SoundHoundAI (SOUN): UP 13.1% last week; UP 140.1% YTD
  3. Digimarc Corporation (DMRC):  UP 0.3% last week; DOWN 36.4% YTD
  4. Verses AI (VRSSF): DOWN 2.7% last week; DOWN 36.5% YTD 
  5. BigBear.ai (BBAI): DOWN 6.7% last week; DOWN 35.0% YTD 
    • BBAI provides AI and machine learning to assist customers in aggregating, interpreting, and synthesizing data to enable real-time decision-making capabilities.
    • Latest news, commentary and/or analysis: 
  6. D-Wave Quantum (QBTS): DOWN 7.1% last week; UP 47.7% YTD:
  7. Applied Optoelectronics (AAOI): DOWN 7.7% last week; DOWN 47.1% YTD
  8. Rekor Systems (REKR): DOWN 12.4% last week; DOWN 49.2% YTD
    • REKR leverages AI, machine learning, and holistic data to support the intelligent infrastructure for smart mobility.
    • Latest news, commentary and/or analysis: None
  9. Rigetti Computing: (RGTI): DOWN 17.1% last week; UP 141.7% YTD
  10. Evolv Technologies (EVLV); DOWN 39.2% last week; DOWN 50.0% YTD 


Summary

As mentioned in the introduction the munKNEE Small Cap AI Stocks Portfolio went UP 3.0% last week which outperformed the Global X Artificial Intelligence & Technology ETF (AIQ) of 91 constituents, which only went UP 0.7%, but the portfolio is still DOWN 26.4% YTD.


More By This Author:

All Cresco Labs' QI Financial Metrics Down Except SG&A
Organigram Q2 Financial Metrics Mixed
Largest Clinical-Stage BioTech Drug Stocks Declined 3% Last Week

STOCKS IN THIS ARTICLE

Comments